Back to Search
Start Over
Effect of AMPK signal pathway on pathogenesis of abdominal aortic aneurysms
- Source :
- Oncotarget
- Publication Year :
- 2017
- Publisher :
- Impact Journals, LLC, 2017.
-
Abstract
- // Le Yang 1 , Lin Shen 2 , Peixian Gao 1 , Gang Li 1 , Yuxiang He 1 , Maohua Wang 1 , Hua Zhou 1 , Hai Yuan 1 , Xing Jin 1 and Xuejun Wu 1 1 Department of Vascular Surgery, Shandong Provincial Hospital affiliated to Shandong University, Jinan 250012, China 2 Department of Ophthalmology, Qilu Hospital of Shandong University, Jinan 250012, China Correspondence to: Xuejun Wu, email: wuxuejun0704@163.com Keywords: AMPK, aneurysm, inflammation, neovascularization, MMP Received: November 18, 2016 Accepted: August 26, 2017 Published: October 07, 2017 ABSTRACT Background and aims: Determine the effect of AMPK activation and inhibition on the development of AAA (abdominal aortic aneurysm). Methods: AAA was induced in ApoE -/- mice by Ang II (Angiotensin II)-infusion. AICAR (5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside) was used as AMPK activator and Compound C was used as AMPK inhibitor. We further investigate the effect of metformin, a widely used anti-diabetic drug which could activate AMPK signal pathway, on the pathogenesis of aneurysm. Results : Phospho-AMPK level was significantly decreased in AAA tissue compared with control aortas. AICAR significantly reduced the incidence, severity and mortality of aneurysm in the Ang II-infusion model. AICAR also alleviated macrophage infiltration and neovascularity in Ang II infusion model at day 28. The expression of pro-inflammatory factors, angiogenic factors and the activity of MMPs were also alleviated by AICAR during AAA induction. On the other hand, Compound C treatment did not exert obvious protective effect. AMPK activation may inhibit the activation of nuclear factor-κB (NF-κB) and signal transducer and activator of transcription-3 (STAT-3) during AAA induction. Administration of metformin also activated AMPK signal pathway and retarded AAA progression in Ang II infusion model. Conclusions : Activation of AMPK signaling pathway may inhibit the Ang II-induced AAA in mice. Metformin may be a promising approach to the treatment of AAA.
- Subjects :
- AMPK
0301 basic medicine
Apolipoprotein E
medicine.medical_specialty
Inflammation
macromolecular substances
030204 cardiovascular system & hematology
Neovascularization
Pathogenesis
03 medical and health sciences
0302 clinical medicine
Internal medicine
medicine
cardiovascular diseases
MMP
Activator (genetics)
business.industry
Angiotensin II
Metformin
030104 developmental biology
Endocrinology
Oncology
inflammation
aneurysm
cardiovascular system
neovascularization
medicine.symptom
business
Research Paper
medicine.drug
Subjects
Details
- ISSN :
- 19492553
- Volume :
- 8
- Database :
- OpenAIRE
- Journal :
- Oncotarget
- Accession number :
- edsair.doi.dedup.....fc7962760a5f5739ee2eedec09d3dc7e
- Full Text :
- https://doi.org/10.18632/oncotarget.21608